4-[[2-(4-chlorophenyl)-5-methyl-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]morpholine;4-[[2-(4-chlorophenyl)-6-(1,2,4-oxadiazol-3-yl)imidazo[1,2-a]pyridin-3-yl]methyl]morpholine;[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl]methyl]piperazin-1-yl]-(4-fluorophenyl)methanone;[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]-1,4-diazepan-1-yl]-(3-fluorophenyl)methanone;[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]-(oxetan-3-yl)methanone;4-[(2-cyclohexyl-6-phenylimidazo[1,2-a]pyridin-3-yl)methyl]morpholine

C159H151Cl5F2N24O8 — CID 159777477

About 4-[[2-(4-chlorophenyl)-5-methyl-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]morpholine;4-[[2-(4-chlorophenyl)-6-(1,2,4-oxadiazol-3-yl)imidazo[1,2-a]pyridin-3-yl]methyl]morpholine;[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl]methyl]piperazin-1-yl]-(4-fluorophenyl)methanone;[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]-1,4-diazepan-1-yl]-(3-fluorophenyl)methanone;[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]-(oxetan-3-yl)methanone;4-[(2-cyclohexyl-6-phenylimidazo[1,2-a]pyridin-3-yl)methyl]morpholine

4-[[2-(4-chlorophenyl)-5-methyl-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]morpholine;4-[[2-(4-chlorophenyl)-6-(1,2,4-oxadiazol-3-yl)imidazo[1,2-a]pyridin-3-yl]methyl]morpholine;[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl]methyl]piperazin-1-yl]-(4-fluorophenyl)methanone;[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]-1,4-diazepan-1-yl]-(3-fluorophenyl)methanone;[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]-(oxetan-3-yl)methanone;4-[(2-cyclohexyl-6-phenylimidazo[1,2-a]pyridin-3-yl)methyl]morpholine (PubChem CID 159777477) has the molecular formula C159H151Cl5F2N24O8 and a molecular weight of 2741.38 g/mol. Its IUPAC name is 4-[[2-(4-chlorophenyl)-5-methyl-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]morpholine;4-[[2-(4-chlorophenyl)-6-(1,2,4-oxadiazol-3-yl)imidazo[1,2-a]pyridin-3-yl]methyl]morpholine;[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl]methyl]piperazin-1-yl]-(4-fluorophenyl)methanone;[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]-1,4-diazepan-1-yl]-(3-fluorophenyl)methanone;[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]-(oxetan-3-yl)methanone;4-[(2-cyclohexyl-6-phenylimidazo[1,2-a]pyridin-3-yl)methyl]morpholine.

Molecular Properties

• Compound Name: 4-[[2-(4-chlorophenyl)-5-methyl-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]morpholine;4-[[2-(4-chlorophenyl)-6-(1,2,4-oxadiazol-3-yl)imidazo[1,2-a]pyridin-3-yl]methyl]morpholine;[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl]methyl]piperazin-1-yl]-(4-fluorophenyl)methanone;[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]-1,4-diazepan-1-yl]-(3-fluorophenyl)methanone;[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]-(oxetan-3-yl)methanone;4-[(2-cyclohexyl-6-phenylimidazo[1,2-a]pyridin-3-yl)methyl]morpholine
• PubChem CID: 159777477
• Molecular Formula: C159H151Cl5F2N24O8
• Molecular Weight: 2741.38 g/mol
• Exact Mass: 2737.06
• IUPAC Name: 4-[[2-(4-chlorophenyl)-5-methyl-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]morpholine;4-[[2-(4-chlorophenyl)-6-(1,2,4-oxadiazol-3-yl)imidazo[1,2-a]pyridin-3-yl]methyl]morpholine;[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl]methyl]piperazin-1-yl]-(4-fluorophenyl)methanone;[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]-1,4-diazepan-1-yl]-(3-fluorophenyl)methanone;[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]-(oxetan-3-yl)methanone;4-[(2-cyclohexyl-6-phenylimidazo[1,2-a]pyridin-3-yl)methyl]morpholine
• SMILES: Cc1c(-c2ccccc2)ccc2nc(-c3ccc(Cl)cc3)c(CN3CCOCC3)n12.Clc1ccc(-c2nc3ccc(-c4ncon4)cn3c2CN2CCOCC2)cc1.O=C(C1COC1)N1CCN(Cc2c(-c3ccc(Cl)cc3)nc3ccc(-c4ccccc4)cn23)CC1.O=C(c1ccc(F)cc1)N1CCN(Cc2c(-c3ccc(Cl)cc3)nc3cnc(-c4ccccc4)cn23)CC1.O=C(c1cccc(F)c1)N1CCCN(Cc2c(-c3ccc(Cl)cc3)nc3ccc(-c4ccccc4)cn23)CC1.c1ccc(-c2ccc3nc(C4CCCCC4)c(CN4CCOCC4)n3c2)cc1
• InChI: InChI=1S/C32H28ClFN4O.C30H25ClFN5O.C28H27ClN4O2.C25H24ClN3O.C24H29N3O.C20H18ClN5O2/c33-27-13-10-24(11-14-27)31-29(38-21-26(12-15-30(38)35-31)23-6-2-1-3-7-23)22-36-16-5-17-37(19-18-36)32(39)25-8-4-9-28(34)20-25;31-24-10-6-22(7-11-24)29-27(37-19-26(33-18-28(37)34-29)21-4-2-1-3-5-21)20-35-14-16-36(17-15-35)30(38)23-8-12-25(32)13-9-23;29-24-9-6-21(7-10-24)27-25(17-31-12-14-32(15-13-31)28(34)23-18-35-19-23)33-16-22(8-11-26(33)30-27)20-4-2-1-3-5-20;1-18-22(19-5-3-2-4-6-19)11-12-24-27-25(20-7-9-21(26)10-8-20)23(29(18)24)17-28-13-15-30-16-14-28;1-3-7-19(8-4-1)21-11-12-23-25-24(20-9-5-2-6-10-20)22(27(23)17-21)18-26-13-15-28-16-14-26;21-16-4-1-14(2-5-16)19-17(12-25-7-9-27-10-8-25)26-11-15(3-6-18(26)23-19)20-22-13-28-24-20/h1-4,6-15,20-21H,5,16-19,22H2;1-13,18-19H,14-17,20H2;1-11,16,23H,12-15,17-19H2;2-12H,13-17H2,1H3;1,3-4,7-8,11-12,17,20H,2,5-6,9-10,13-16,18H2;1-6,11,13H,7-10,12H2
• InChIKey: NGXVLKJZNACTCT-UHFFFAOYSA-N
• XLogP: 31.12
• TPSA: 272.90 Ų
• H-Bond Acceptors: 29
• Rotatable Bonds: 27
• Heavy Atoms: 198
• Complexity: —

Lipinski Rule of Five

3 violations

Rule	Value
MW ≤ 500	2741.38
LogP ≤ 5	31.12
H-Bond Donors ≤ 5	0
H-Bond Acceptors ≤ 10	29

Frequently Asked Questions

What is the IUPAC name of 4-[[2-(4-chlorophenyl)-5-methyl-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]morpholine;4-[[2-(4-chlorophenyl)-6-(1,2,4-oxadiazol-3-yl)imidazo[1,2-a]pyridin-3-yl]methyl]morpholine;[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl]methyl]piperazin-1-yl]-(4-fluorophenyl)methanone;[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]-1,4-diazepan-1-yl]-(3-fluorophenyl)methanone;[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]-(oxetan-3-yl)methanone;4-[(2-cyclohexyl-6-phenylimidazo[1,2-a]pyridin-3-yl)methyl]morpholine?

The IUPAC name of 4-[[2-(4-chlorophenyl)-5-methyl-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]morpholine;4-[[2-(4-chlorophenyl)-6-(1,2,4-oxadiazol-3-yl)imidazo[1,2-a]pyridin-3-yl]methyl]morpholine;[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl]methyl]piperazin-1-yl]-(4-fluorophenyl)methanone;[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]-1,4-diazepan-1-yl]-(3-fluorophenyl)methanone;[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]-(oxetan-3-yl)methanone;4-[(2-cyclohexyl-6-phenylimidazo[1,2-a]pyridin-3-yl)methyl]morpholine (CID 159777477) is 4-[[2-(4-chlorophenyl)-5-methyl-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]morpholine;4-[[2-(4-chlorophenyl)-6-(1,2,4-oxadiazol-3-yl)imidazo[1,2-a]pyridin-3-yl]methyl]morpholine;[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl]methyl]piperazin-1-yl]-(4-fluorophenyl)methanone;[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]-1,4-diazepan-1-yl]-(3-fluorophenyl)methanone;[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]-(oxetan-3-yl)methanone;4-[(2-cyclohexyl-6-phenylimidazo[1,2-a]pyridin-3-yl)methyl]morpholine.

What is the SMILES notation for 4-[[2-(4-chlorophenyl)-5-methyl-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]morpholine;4-[[2-(4-chlorophenyl)-6-(1,2,4-oxadiazol-3-yl)imidazo[1,2-a]pyridin-3-yl]methyl]morpholine;[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl]methyl]piperazin-1-yl]-(4-fluorophenyl)methanone;[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]-1,4-diazepan-1-yl]-(3-fluorophenyl)methanone;[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]-(oxetan-3-yl)methanone;4-[(2-cyclohexyl-6-phenylimidazo[1,2-a]pyridin-3-yl)methyl]morpholine?

The canonical SMILES for 4-[[2-(4-chlorophenyl)-5-methyl-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]morpholine;4-[[2-(4-chlorophenyl)-6-(1,2,4-oxadiazol-3-yl)imidazo[1,2-a]pyridin-3-yl]methyl]morpholine;[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl]methyl]piperazin-1-yl]-(4-fluorophenyl)methanone;[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]-1,4-diazepan-1-yl]-(3-fluorophenyl)methanone;[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]-(oxetan-3-yl)methanone;4-[(2-cyclohexyl-6-phenylimidazo[1,2-a]pyridin-3-yl)methyl]morpholine is Cc1c(-c2ccccc2)ccc2nc(-c3ccc(Cl)cc3)c(CN3CCOCC3)n12.Clc1ccc(-c2nc3ccc(-c4ncon4)cn3c2CN2CCOCC2)cc1.O=C(C1COC1)N1CCN(Cc2c(-c3ccc(Cl)cc3)nc3ccc(-c4ccccc4)cn23)CC1.O=C(c1ccc(F)cc1)N1CCN(Cc2c(-c3ccc(Cl)cc3)nc3cnc(-c4ccccc4)cn23)CC1.O=C(c1cccc(F)c1)N1CCCN(Cc2c(-c3ccc(Cl)cc3)nc3ccc(-c4ccccc4)cn23)CC1.c1ccc(-c2ccc3nc(C4CCCCC4)c(CN4CCOCC4)n3c2)cc1.

What is the InChIKey of 4-[[2-(4-chlorophenyl)-5-methyl-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]morpholine;4-[[2-(4-chlorophenyl)-6-(1,2,4-oxadiazol-3-yl)imidazo[1,2-a]pyridin-3-yl]methyl]morpholine;[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl]methyl]piperazin-1-yl]-(4-fluorophenyl)methanone;[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]-1,4-diazepan-1-yl]-(3-fluorophenyl)methanone;[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]-(oxetan-3-yl)methanone;4-[(2-cyclohexyl-6-phenylimidazo[1,2-a]pyridin-3-yl)methyl]morpholine?

The InChIKey is NGXVLKJZNACTCT-UHFFFAOYSA-N. The full InChI is InChI=1S/C32H28ClFN4O.C30H25ClFN5O.C28H27ClN4O2.C25H24ClN3O.C24H29N3O.C20H18ClN5O2/c33-27-13-10-24(11-14-27)31-29(38-21-26(12-15-30(38)35-31)23-6-2-1-3-7-23)22-36-16-5-17-37(19-18-36)32(39)25-8-4-9-28(34)20-25;31-24-10-6-22(7-11-24)29-27(37-19-26(33-18-28(37)34-29)21-4-2-1-3-5-21)20-35-14-16-36(17-15-35)30(38)23-8-12-25(32)13-9-23;29-24-9-6-21(7-10-24)27-25(17-31-12-14-32(15-13-31)28(34)23-18-35-19-23)33-16-22(8-11-26(33)30-27)20-4-2-1-3-5-20;1-18-22(19-5-3-2-4-6-19)11-12-24-27-25(20-7-9-21(26)10-8-20)23(29(18)24)17-28-13-15-30-16-14-28;1-3-7-19(8-4-1)21-11-12-23-25-24(20-9-5-2-6-10-20)22(27(23)17-21)18-26-13-15-28-16-14-26;21-16-4-1-14(2-5-16)19-17(12-25-7-9-27-10-8-25)26-11-15(3-6-18(26)23-19)20-22-13-28-24-20/h1-4,6-15,20-21H,5,16-19,22H2;1-13,18-19H,14-17,20H2;1-11,16,23H,12-15,17-19H2;2-12H,13-17H2,1H3;1,3-4,7-8,11-12,17,20H,2,5-6,9-10,13-16,18H2;1-6,11,13H,7-10,12H2.

What are the key properties of 4-[[2-(4-chlorophenyl)-5-methyl-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]morpholine;4-[[2-(4-chlorophenyl)-6-(1,2,4-oxadiazol-3-yl)imidazo[1,2-a]pyridin-3-yl]methyl]morpholine;[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl]methyl]piperazin-1-yl]-(4-fluorophenyl)methanone;[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]-1,4-diazepan-1-yl]-(3-fluorophenyl)methanone;[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]-(oxetan-3-yl)methanone;4-[(2-cyclohexyl-6-phenylimidazo[1,2-a]pyridin-3-yl)methyl]morpholine?

4-[[2-(4-chlorophenyl)-5-methyl-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]morpholine;4-[[2-(4-chlorophenyl)-6-(1,2,4-oxadiazol-3-yl)imidazo[1,2-a]pyridin-3-yl]methyl]morpholine;[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl]methyl]piperazin-1-yl]-(4-fluorophenyl)methanone;[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]-1,4-diazepan-1-yl]-(3-fluorophenyl)methanone;[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]-(oxetan-3-yl)methanone;4-[(2-cyclohexyl-6-phenylimidazo[1,2-a]pyridin-3-yl)methyl]morpholine has a molecular weight of 2741.38 g/mol, XLogP of 31.12, 27 rotatable bonds, 0 hydrogen bond donors, and 29 hydrogen bond acceptors.

Where does this data come from?

All data for 4-[[2-(4-chlorophenyl)-5-methyl-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]morpholine;4-[[2-(4-chlorophenyl)-6-(1,2,4-oxadiazol-3-yl)imidazo[1,2-a]pyridin-3-yl]methyl]morpholine;[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl]methyl]piperazin-1-yl]-(4-fluorophenyl)methanone;[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]-1,4-diazepan-1-yl]-(3-fluorophenyl)methanone;[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]-(oxetan-3-yl)methanone;4-[(2-cyclohexyl-6-phenylimidazo[1,2-a]pyridin-3-yl)methyl]morpholine is sourced from PubChem (CID 159777477), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).